<DOC>
	<DOCNO>NCT02328677</DOCNO>
	<brief_summary>ColoCare international prospective cohort study stage I-IV colorectal cancer patient ( ICD-10 C18-C20 ) .</brief_summary>
	<brief_title>ColoCare Study - Colorectal Cancer Cohort</brief_title>
	<detailed_description>The ColoCare Consortium multicenter initiative establish international cohort colorectal cancer ( CRC ) patient interdisciplinary study CRC prognosis outcomes sit Fred Hutchinson Cancer Research Center , Seattle ( Washington , USA ) , H. Lee Moffitt Cancer Center Research Institute , Tampa ( Florida , USA ) , University Hospital Heidelberg ( Germany ) Huntsman Cancer Institute ( Utah , USA ) . Aims : The ColoCare Study investigate clinical outcome , include disease-free overall survival , predictor cancer recurrence , survival , health-related quality-of-life treatment toxicity . In addition , cross-sectional analysis biomarkers and/or health behavior undertake . Patients recruited baseline ( time first diagnosis ) follow 5 year regular timepoints ( 3m , 6m , 12m , 24m , 36m , 48m , 60m ) . The cohort include comprehensive collection specimen data .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>1 . Age 1889 year ; 2 . Men Women 3 . Newlydiagnosed colon rectal cancer ( stage IIV ) ; CRC treatment ( FHCRC HCI ) 4 . English ( FHCRC , Moffitt , HCI ) German ( University Hospital Heidelberg ) speaking ; 5. mentally/physically able consent participate . one fulfil insufficient language consent capacity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Colorectal cancer</keyword>
	<keyword>rectosigmoid</keyword>
	<keyword>rectum</keyword>
	<keyword>colon</keyword>
</DOC>